Advertisement

Topics

FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing

10:07 EDT 12 Oct 2018 | FinanzNachrichten

Test Offers Shortest Time to Reportable Results For US Hospitals, Reference Labs and Blood Centers - Efficient system analyzes 37 antigens of 10 blood group systems - Helps minimize allo-immunizat...

Original Article: FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing"

Advertisement
Quick Search
Advertisement
Advertisement